89 related articles for article (PubMed ID: 8594878)
1. In vivo and in vitro pressor effects of erythropoietin in rats.
Vaziri ND; Zhou XJ; Smith J; Oveisi F; Baldwin K; Purdy RE
Am J Physiol; 1995 Dec; 269(6 Pt 2):F838-45. PubMed ID: 8594878
[TBL] [Abstract][Full Text] [Related]
2. Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure.
Vaziri ND; Zhou XJ; Naqvi F; Smith J; Oveisi F; Wang ZQ; Purdy RE
Am J Physiol; 1996 Jul; 271(1 Pt 1):E113-22. PubMed ID: 8760088
[TBL] [Abstract][Full Text] [Related]
3. Defective calcium signalling in uraemic platelets and its amelioration with long-term erythropoietin therapy.
Zhou XJ; Vaziri ND
Nephrol Dial Transplant; 2002 Jun; 17(6):992-7. PubMed ID: 12032187
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-mediated effect of erythropoietin on blood pressure and renal hemodynamics in hypertensive rats.
Tojo A; Doumoto M; Oka K; Numabe A; Kimura K; Yagi S
Am J Physiol; 1996 Apr; 270(4 Pt 2):R744-8. PubMed ID: 8967402
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin-induced hypertension in rat is not mediated by alterations of plasma endothelin, vasopressin, or atrial natriuretic peptide levels.
Zhou XJ; Pandian D; Wang XQ; Vaziri ND
J Am Soc Nephrol; 1997 Jun; 8(6):901-5. PubMed ID: 9189856
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin stimulates atrial natriuretic peptide secretion from adult rat cardiac atrium.
Porat O; Neumann D; Zamir O; Nachshon S; Feigin E; Cohen J; Zamir N
J Pharmacol Exp Ther; 1996 Mar; 276(3):1162-8. PubMed ID: 8786548
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide metabolism in erythropoietin-induced hypertension: effect of calcium channel blockade.
Ni Z; Wang XQ; Vaziri ND
Hypertension; 1998 Oct; 32(4):724-9. PubMed ID: 9774370
[TBL] [Abstract][Full Text] [Related]
8. Prevention of erythropoietin-associated hypertension.
Lee MS; Lee JS; Lee JY
Hypertension; 2007 Aug; 50(2):439-45. PubMed ID: 17548719
[TBL] [Abstract][Full Text] [Related]
9. [Effect of human recombinant erythropoietin (Epo) on cellular Ca2+, Na+, and K+ regulation of vascular smooth muscle cells grown in vitro--a new insight into the pathogenesis of Epo induced hypertension].
Kuriyama S; Tokudome G; Tomonari H; Matsumoto H; Utsunomiya Y; Horiguchi M; Uchida H; Hashimoto T; Sakai O
Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):671-8. PubMed ID: 8377279
[TBL] [Abstract][Full Text] [Related]
10. Sustained systemic arterial hypertension induced by extended hypobaric hypoxia.
Vaziri ND; Wang ZQ
Kidney Int; 1996 May; 49(5):1457-63. PubMed ID: 8731114
[TBL] [Abstract][Full Text] [Related]
11. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO).
Kirkeby A; Torup L; Bochsen L; Kjalke M; Abel K; Theilgaard-Monch K; Johansson PI; Bjørn SE; Gerwien J; Leist M
Thromb Haemost; 2008 Apr; 99(4):720-8. PubMed ID: 18392330
[TBL] [Abstract][Full Text] [Related]
12. The influence of erythropoietin on the vascular responses of rat resistance arteries.
Wu XC; Richards NT; Johns EJ
Exp Physiol; 1999 Sep; 84(5):917-27. PubMed ID: 10502659
[TBL] [Abstract][Full Text] [Related]
13. Effect of chronic and short-term erythropoietin treatment on random flap survival in rats: an experimental study.
Saray A; Ozakpinar R; Koc C; Serel S; Sen Z; Can Z
Laryngoscope; 2003 Jan; 113(1):85-9. PubMed ID: 12514388
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro.
Wen Y; Zhang XJ; Ma YX; Xu XJ; Hong LF; Lu ZH
Scand J Clin Lab Invest; 2009; 69(4):518-25. PubMed ID: 19347742
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin induces Ca2+ mobilization and contraction in rat mesangial and aortic smooth muscle cultures.
Morakkabati N; Gollnick F; Meyer R; Fandrey J; Jelkmann W
Exp Hematol; 1996 Feb; 24(2):392-7. PubMed ID: 8641371
[TBL] [Abstract][Full Text] [Related]
16. The effect of centrally administered erythropoietin on cardiovascular and respiratory system of anaesthetized rats.
Yalcin M; Ak F; Cangul IT; Erturk M
Auton Neurosci; 2007 Jul; 134(1-2):1-7. PubMed ID: 17306629
[TBL] [Abstract][Full Text] [Related]
17. Correlation of blood pressure in end-stage renal disease with platelet cytosolic free calcium concentration during treatment of renal anemia with recombinant human erythropoietin.
Schiffl H
Int J Artif Organs; 1992 Jun; 15(6):343-8. PubMed ID: 1639525
[TBL] [Abstract][Full Text] [Related]
18. Adrenocorticotropic hormone, blood pressure, and serum erythropoietin concentrations in the rat.
Zhang Y; Andrews MC; Schyvens CG; McKenzie KU; Whitworth JA
Am J Hypertens; 2004 May; 17(5 Pt 1):457-61. PubMed ID: 15110907
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.
van der Meer P; Lipsic E; Henning RH; Boddeus K; van der Velden J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
J Am Coll Cardiol; 2005 Jul; 46(1):125-33. PubMed ID: 15992646
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin receptor-operated Ca2+ channels: activation by phospholipase C-gamma 1.
Marrero MB; Venema RC; Ma H; Ling BN; Eaton DC
Kidney Int; 1998 May; 53(5):1259-68. PubMed ID: 9573541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
